Bi-ventricular pacing in congestive cardiac failure. Current experience and future directions

European Heart Journal

Volumn 21, Issue 11, 2000, Pages 884-889

  Walker, S ^a   Levy, T M ^a   Coats, A J S ^a   Peters, N S ^a   Paul, V E ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HEART PACING; HUMAN; PRIORITY JOURNAL; REVIEW; THORACOSCOPY; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; CORONARY ANGIOGRAPHY; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS;

EID: 0034025968     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1913     Document Type: Review

References (48)

1. Mosterd A, Hoes A, de Bruyne M. Prevalence of heart failure and left ventricular dysfunction in the general population. Eur Heart J. 20:1999;447-455.
2. Cowie M, Wood D, Coats A. Incidence and aetiology of heart failure: A population based study. Eur Heart J. 20:1999;421-428.
3. Kjekshus J, Swedberg K, Snapinn S. Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS Trial Group. Am J Cardiol. 69:1992;103-107.
4. Anonymous. The cardiac insufficiency bisoprolol study II (CIBIS II): a randomised trial. Lancet. 353:1999;9-13.
5. Anonymous. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group [see comments]. N Engl J Med. 336:1997;525-533.
6. Dracup K, Walden JA, Stevenson LW, Brecht ML. Quality of life in patients with advanced heart failure. J Heart Lung Transplant. 11:1992;273-279.
7. Fryback DG, Dasbach EJ, Klein R. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decision Making. 13:1993;89-102.
8. Cohn JN, Archibald DG, Ziesche S. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 314:1986;1547-1552.
9. Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. Circulation. 87:1993;VI24-31.
10. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) [see comments]. Lancet. 344:1994;493-498.
11. Lamp B, Hammel D, Kerber S, Deng M, Breithardt G, Block M. Multi-site pacing in severe heart failure - how many patients are eligible? PACE. 21:1998;736.
12. Schaldach, M, How many patients with Heart failure are appropriate for biventricular pacing? Cardiostim, 1998, Lisbon.
13. Murkofsky RL, Dangas G, Diamond JA, Mehta D, Schaffer A, Ambrose JA. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction [see comment]. J Am Coll Cardiol. 32:1998;476-482.
14. Rahko PS, Shaver JA, Salerni R. Evaluation of mechanical events and systolic function in dilated cardiomyopathy: comparison between patients with and without left bundle branch block. Acta Cardiologica. 43:1988;179-184.
15. Shaver JA, Rahko PS, Grines CL, Boudoulas H, Wooley CF. Effects of left bundle branch block on the events of the cardiac cycle. Acta Cardiologica. 43:1988;459-467.
16. Baragan J, Fernandez-Caamano F, Sozutek Y, Coblence B, Lenegre J. Chronic left complete bundle-branch block. Phonocardiographic and mechanocardiographic study of 30 cases. Br Heart J. 30:1968;196-202.
17. Wilensky RL, Yudelman P, Cohen AI. Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy. Am J Cardiol. 62:1988;276-283.
18. Xiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol. 53:1996;163-170.
19. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [see comments]. Circulation. 95:1997;2660-2667.
20. Cianfrocca C, Pelliccia F, Nigri A, Critelli G. Resting and ambulatory ECG predictors of mode of death in dilated cardiomyopathy. J Electrocardiol. 25:1992;295-303.
21. Saxon LA, Kerwin WF, Cahalan MK. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol. 9:1998;13-21.
22. Cazeau S, Ritter P, Bakdach S. Four chamber pacing in dilated cardiomyopathy [see comments]. PACE. 17:1994;1974-1979.
23. Bakker P, Meiburg H, de Jonge N. Beneficial effects of biventricular pacing in congestive heart failure (Abstr). PACE. 17:1994;820.
24. Foster AH, Gold MR, McLaughlin JS. Acute hemodynamic effects of atrio-biventricular pacing in humans [see comments]. Ann Thoracic Surg. 59:1995;294-300.
25. Cazeau S, Ritter P, Lazarus A. Multisite pacing for end-stage heart failure: early experience. PACE. 19:1996;1748-1757.
26. Blanc JJ, Etienne Y, Gilard M. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation. 96:1997;3273-3277.
27. Leclercq C, Cazeau S, Le Breton H. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol. 32:1998;1825-1831.
28. Daubert JC, Ritter P, Le Breton H. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. PACE. 21:1998;239-245.
29. Bai Y, Strathmore N, Mond H, Grigg L, Hunt D. Permanent ventricular pacing via the great cardiac vein. PACE. 17:1994;678-683.
30. Gras D, Mabo P, Tang T. Multi-site pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync study. PACE. 21:1998;2249-2255.
31. Daubert J, Linde C, Cazeau S, Sutton R, Kappenberger L, Bailleul C. Protocol design of the MUSTIC (multi-site stimulation in cardiomyopathy) study (Abstr). Arch Maladies Coeur Vaisseur. 91:1998;154.
32. Stellbrink C, Auricchio A, Diem B. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. Am J Cardiol. 83:1999;143D-150D.
33. Auricchio A, Stellbrink C, Sack S. The pacing therapies for congestive heart failure (PATH-CHF) study: Rationale, design, and endpoints of a prospective randomised multicentre study. Am J Cardiol. 83:1999;130D-135D.
34. Auricchio A, Ding J, Kramer A. Comparison of left ventricular pacing sites for heart failure patients. Circulation. 98:1998;302.
35. Auricchio A, Klein H, Tockman B. Transvenous biventricular pacing for heart failure: can the obstacles be overcome? Am J Cardiol. 83:1999;136D-142D.
36. Walker S, Levy T, Rex S, Paul V. The use of a 'side-wire' permanent transvenous pacing electrode for left ventricular pacing. Europace. 1:1999;197-200.
37. Kass D, Chen C, Fetics B, Talbot M, Nevo E, Nakayama M. Ventricular function in patients with dilated cardiomyopathy is improved by VDD pacing at left but not right ventricular sites. J Am Coll Cardiol. 1998:1998;1015-1029.
38. Auricchio A, Kadhiresan V, Ding J. Is QRS width a predictor of acute haemodynamic response during pacing in heart failure patients? PACE. 22:1999;233.
39. Alonso C, Leclercq C, Pavin D, Victor F, Mabo P, Daubert J. ECG predictive factors of positive response to multisite biventricular pacing in advanced heart failure. PACE. 22:1999;232.
40. Krahnefeld O, Vogt J, Tenderich G. Changes in QRS-duration in patients with bi-ventricular pacing system for congestive heart failure treatment and clinical outcome. PACE. 22:1999;133.
41. Puglisi A, Neja C, Risa M. Cardiac resynchronisation: Does patient NYHA class at implant result in differing patient response at follow up? PACE. 22:1999;201.
42. Bucknall C, Holt P, Chathoor R. Heart failure patient response to atrial synchronous biventricular pacing: Impact of presence of 1st degree AV block. PACE. 22:1999;314.
43. N Engl J Med. 337:1997;1576-1583.
44. Guarnieri T, Levine JH, Griffith LS, Veltri EP. When 'sudden cardiac death' is not so sudden: lessons learned from the automatic implantable defibrillator. Am Heart J. 115:1988;205-207.
45. Kim SG. Implantable defibrillator therapy: does it really prolong life? How can we prove it? Am J Cardiol. 71:1993;1213-1218.
46. LeFranc P, Klug D, Lacroix D. Triple chamber pacemaker for end-stage heart failure in a patient with a previously implanted automatic defibrillator. PACE. 21:1998;1672-1675.
47. Walker S, Levy T, Brant S, Gadd P, Paul V. Utilisation simultanee d'un defibrillateur automatique implantable chez un patient prealablement appareille avec un stimulateur cardiaque biventriculaire pour une insuffisance cardiaque terminale. Arch Malad Coeur Vaisseaux. 92:1999;1795-1799.
48. Calkins H, Brinker J, Veltri EP, Guarnieri T, Levine JH. Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators. J Am Coll Cardiol. 16:1990;666-673.